LARITIN 20/120mg – Pediatric Antimalarial Combination Therapy (12 Tablets)
LARITIN 20/120mg Tablets are a fixed-dose antimalarial combination of **Artemether (20mg)** and **Lumefantrine (120mg)**. This formulation is specially designed for children and small-bodied individuals in the treatment of uncomplicated malaria caused by Plasmodium falciparum, including strains resistant to other antimalarials. It offers fast parasite clearance, high treatment success rates, and is part of the WHO-recommended ACT (Artemisinin-based Combination Therapy) regimen.
Product Details
- Brand Name: LARITIN
- Active Ingredients: Artemether 20mg + Lumefantrine 120mg
- Form: Oral tablets
- Pack Size: 12 tablets (typically for a full 3-day treatment course)
- Drug Class: Artemisinin-based Combination Therapy (ACT)
- Target Use: Pediatric and low-weight patients
Composition & Ingredients
Each tablet contains:
- Artemether – 20 mg
- Lumefantrine – 120 mg
Inactive Ingredients: May include lactose, magnesium stearate, maize starch, and other approved excipients (may vary by manufacturer).
Uses and Indications
LARITIN 20/120 is used for the treatment of:
- Uncomplicated malaria caused by Plasmodium falciparum
- Mixed malaria infections where P. falciparum is confirmed or suspected
Key Benefits
- Fast-acting relief from malaria symptoms
- Highly effective in children and small-bodied individuals
- Targets drug-resistant malaria parasites
- Part of WHO-recommended malaria treatment protocol
How to Use
LARITIN 20/120 is usually taken as a 3-day course in six doses (two tablets per dose). Tablets should be taken with food, preferably a fatty meal or milk, to improve absorption. Follow the dosage instructions provided by your healthcare provider. Complete the full course even if the child feels better before finishing it.